SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
August 9, 2023	SC14D9C	Written public communication by the subject company relating to a tender offer by a third party	0001193125-23-207468.pdf 0001193125-23-207468.rtf 0001193125-23-207468.xls View HTML
June 14, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-027990.pdf 0000950170-23-027990.rtf 0000950170-23-027990.xls View HTML
June 14, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-027992.pdf 0000950170-23-027992.rtf 0000950170-23-027992.xls View HTML
June 14, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-027996.pdf 0000950170-23-027996.rtf 0000950170-23-027996.xls View HTML
June 14, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-027998.pdf 0000950170-23-027998.rtf 0000950170-23-027998.xls View HTML
June 13, 2023	8-K	Report of unscheduled material events or corporate event	0000950170-23-027704.pdf 0000950170-23-027704.rtf 0000950170-23-027704.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
May 15, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000950170-23-021967.pdf 0000950170-23-021967.rtf 0000950170-23-021967.xls EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT View HTML
April 28, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0000950170-23-015486.pdf 0000950170-23-015486.rtf 0000950170-23-015486.xls View HTML
April 28, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0000950170-23-015491.pdf 0000950170-23-015491.rtf View HTML
April 28, 2023	ARS	An annual report to security holders	0000950170-23-015495.pdf 0000950170-23-015495.rtf View HTML

Data provided by Kaleidoscope.

Main Corporate Nav